The measurement of plasma
insulin is important for clinical diagnosis of diabetes and for preclinical research of
metabolic diseases, especially in rodent models used in drug discovery research for
type 2 diabetes. Fasting immunoreactive
insulin (F-IRI) concentrations are used to calculate the homeostasis model assessment ratio (HOMA-R), an index of
insulin sensitivity. However, even the most sensitive commercially available
enzyme-linked
immunosorbent assay (ELISA) kits cannot measure the very low F-IRI concentrations in normal rats and mice. Therefore, we sought to develop a new rodent
insulin ELISA with greater sensitivity for low F-IRI concentrations. Despite repeated efforts, high-affinity
antibodies could not be generated by immunizing mice with mouse
insulin (
self-antigen). Therefore, we generated two weak
monoclonal antibodies (13G4 and 26B2) that were affinity maturated and used to develop a highly sensitive ELISA. The measurement range of the sandwich ELISA with the affinity maturated
antibodies (13G4m1 and 26B2m1) was 1.5 to 30,000 pg/ml, and its detection limit was at least 10 times lower than those of commercially available kits. In conclusion, we describe the development of a new ultrasensitive ELISA suitable for measuring very low plasma
insulin concentrations in rodents. This ELISA might be very useful in drug discovery research in diabetes.